Cite

HARVARD Citation

    Thibaud, S. et al. (2020). Protective role of Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukaemia and COVID‐19. British journal of haematology. pp. e73-e76. [Online]. 
  
Back to record